Skip to content
POM-V Prescription Required Companion Animal

Reconcile 8 mg Chewable Tablets for Dogs

Active ingredient: Fluoxetine

Form

Tablet

Species

Dogs

Manufacturer

Forte Healthcare Limited

VMD MA No.

27819/5002

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Fluoxetine

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Reconcile 8 mg Chewable Tablets for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

improvement is noted within 4 weeks, case management should be re-evaluated.
Clinical studies have shown that a beneficial response has been demonstrated for up
to 8 weeks treatment with fluoxetine.
The veterinary medicinal product may be given with or without food. The tablets are
flavoured and most dogs will consume the tablet when offered by the owner.
If a dose is missed, the next scheduled dose should be administered as prescribed.
At the end of treatment, it is not necessary to taper or reduce doses because of the
long half-life of this veterinary medicinal product.
Do not use in dogs weighing less than 4kg.
AN: 03537/2025Page 2 of 6
Do not use in dogs with epilepsy or in dogs with a history of seizures.
Do not use in case of hypersensitivity to fluoxetine or other Selective Serotonin Re-
Uptake Inhibitors (SSRIs) or to any of the excipients.
Target species: Dogs
Very common
(>1 animal / 10 animals treated):
Decreased appetite (including anorexia)
Lethargy
Common
(1 to 10 animals / 100 animals
treated):
Urinary tract disorders (cystitis, urinary
incontinence, urinary retention, stranguria)
Central nervous system signs (incoordination,
disorientation)
Uncommon
(1 to 10 animals / 1,000 animals
treated):
Weight loss/loss of condition
Mydriasis
Rare
(1 to 10 animals / 10,000 animals
treated):
Panting,
Seizures
Vomiting
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
AN: 03537/2025Page 3 of 6
either the marketing authorisation holder or the national competent authority via the
national reporting system.
See the package leaflet for respective contact details.
None.

Special precautions for safe use in the target species:
The safety of the product has not been established in dogs less than 6 months of age
or weighing less than 4kg.
Though rare, seizures may occur in dogs treated with the veterinary medicinal
product. Treatment should be stopped if seizures occur.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician. In humans, the most common symptoms
associated with overdose include seizures, somnolence, nausea, tachycardia, and
vomiting.
Special precautions for the protection of the environment:
Not applicable.
The veterinary medicinal product should not be given concomitantly with veterinary
medicinal products that lower the seizure threshold (e.g. phenothiazines such as
acepromazine or chlorpromazine).
Do not use the product in conjunction with other serotonergic agents (e.g. sertraline)
and monoamine oxidase inhibitors (MAOIs) [e.g. selegiline hydrochloride (L-
deprenyl), amitraz] or tricyclic amines (TCAs) (e.g. amitriptyline and clomipramine).
A 6-week washout interval should be observed following discontinuation of therapy
with the product prior to the administration of any veterinary medicinal product that
may adversely interact with fluoxetine or its metabolite, norfluoxetine.
Fluoxetine is largely metabolised by the P-450 enzyme system, although the precise
isoform in dogs is unknown. Therefore, fluoxetine should be used with caution with
other veterinary medicinal products.
Store below 30 °C.
Store in the original container.
Keep the bottle tightly closed in order to protect from moisture.
Do not remove the desiccant.
Not applicable.
4.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.